Allodi and colleagues show that higher levels of IGF-2 (insulin-like growth factor 2) and IGF-1 receptors in oculomotor neurons during ALS could play a role in oculomotor resistance. The gene discussed is IGF2; the disease is amyotrophic lateral sclerosis.